CRLCHARLES RIVER LABORATORIES ...

NYSE criver.com


$ 203.98 $ 2.11 (1.05 %)    

Monday, 19-Aug-2024 13:13:41 EDT
QQQ $ 477.04 $ 1.38 (0.29 %)
DIA $ 408.95 $ 1.52 (0.37 %)
SPY $ 557.04 $ 2.15 (0.39 %)
TLT $ 97.93 $ -0.01 (-0.01 %)
GLD $ 231.45 $ 1.25 (0.54 %)
$ 201.87
$ 202.62
$ 203.85 x 153
$ 204.19 x 100
$ 201.69 - $ 204.55
$ 161.65 - $ 275.00
436,716
na
10.47B
$ 1.33
$ 23.71
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2024 06-29-2024 10-Q
2 05-09-2024 03-30-2024 10-Q
3 02-14-2024 12-30-2023 10-K
4 11-08-2023 09-30-2023 10-Q
5 08-09-2023 07-01-2023 10-Q
6 05-11-2023 04-01-2023 10-Q
7 02-22-2023 12-31-2022 10-K
8 11-02-2022 09-24-2022 10-Q
9 08-03-2022 06-25-2022 10-Q
10 05-04-2022 03-26-2022 10-Q
11 02-16-2022 12-25-2021 10-K
12 11-03-2021 09-25-2021 10-Q
13 08-04-2021 06-26-2021 10-Q
14 05-04-2021 03-27-2021 10-Q
15 02-17-2021 12-26-2020 10-K
16 11-09-2020 09-26-2020 10-Q
17 10-29-2020 09-26-2020 10-Q
18 08-05-2020 06-27-2020 10-Q
19 05-07-2020 03-28-2020 10-Q
20 02-11-2020 12-28-2019 10-K
21 11-06-2019 09-28-2019 10-Q
22 07-31-2019 06-29-2019 10-Q
23 05-07-2019 03-30-2019 10-Q
24 02-13-2019 12-29-2018 10-K
25 11-07-2018 09-29-2018 10-Q
26 08-08-2018 06-30-2018 10-Q
27 05-10-2018 03-31-2018 10-Q
28 02-13-2018 12-30-2017 10-K
29 11-09-2017 09-30-2017 10-Q
30 08-09-2017 07-01-2017 10-Q
31 05-10-2017 04-01-2017 10-Q
32 02-14-2017 12-31-2016 10-K
33 11-02-2016 09-24-2016 10-Q
34 08-03-2016 06-25-2016 10-Q
35 05-04-2016 03-26-2016 10-Q
36 02-12-2016 12-26-2015 10-K
37 11-04-2015 09-26-2015 10-Q
38 07-30-2015 06-27-2015 10-Q
39 04-30-2015 03-28-2015 10-Q
40 02-17-2015 12-27-2014 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 td-cowen-maintains-hold-on-charles-river-lowers-price-target-to-203

TD Cowen analyst Charles Rhyee maintains Charles River (NYSE:CRL) with a Hold and lowers the price target from $228 to $203.

 warner-bros-airbnb-and-monster-beverage-are-among-top-10-large-cap-losers-last-week-aug-4-aug-10-are-the-others-in-your-portfolio

These 10 stocks had the biggest drop last week, with McKesson Corporation, BIO-TECHNE Corp, and Warner Bros. Discovery, Inc. be...

 barclays-maintains-equal-weight-on-charles-river-lowers-price-target-to-210

Barclays analyst Luke Sergott maintains Charles River (NYSE:CRL) with a Equal-Weight and lowers the price target from $230 t...

 ubs-maintains-buy-on-charles-river-lowers-price-target-to-240

UBS analyst Dan Brennan maintains Charles River (NYSE:CRL) with a Buy and lowers the price target from $290 to $240.

 evercore-isi-group-maintains-outperform-on-charles-river-lowers-price-target-to-225

Evercore ISI Group analyst Ross Muken maintains Charles River (NYSE:CRL) with a Outperform and lowers the price target from ...

 goldman-sachs-maintains-buy-on-charles-river-lowers-price-target-to-250

Goldman Sachs analyst Matthew Sykes maintains Charles River (NYSE:CRL) with a Buy and lowers the price target from $290 to $...

 jp-morgan-downgrades-charles-river-to-neutral-lowers-price-target-to-205

JP Morgan analyst Casey Woodring downgrades Charles River (NYSE:CRL) from Overweight to Neutral and lowers the price target ...

 baird-downgrades-charles-river-to-neutral-lowers-price-target-to-191

Baird analyst Eric Coldwell downgrades Charles River (NYSE:CRL) from Outperform to Neutral and lowers the price target from ...

 wall-street-ends-wednesday-in-the-red-as-risk-sentiment-remains-fragile-sp-500-movers-at-the-close

U.S. markets close lower on Wednesday after bounce back on Tuesday, with small caps hit hardest. Investors assess economic outl...

 charles-river-laboratories-stock-sinks-as-it-warns-of-continued-biotech-demand-slump-lowers-forecast

Charles River Laboratories reported Q2 2024 revenue of $1.03 billion, a 3.2% decrease year-over-year, surpassing the $1.024 bil...

 charles-river-q2-2024-adj-eps-280-beats-239-estimate-sales-103b-beat-1024b-estimate

Charles River (NYSE:CRL) reported quarterly earnings of $2.80 per share which beat the analyst consensus estimate of $2.39 by 1...

 charles-river-and-autobahn-labs-establish-partnership-to-accelerate-academic-discoveries-into-novel-therapeutics-charles-river-to-make-equity-investment-in-autobahn-labs-chief-scientific-officer-justin-bryans-named-to-autobahns-board-of-directors

Agreement establishes Charles River as the preferred partner for Autobahn Labs, leveraging drug discovery and development capab...

 baird-maintains-outperform-on-charles-river-lowers-price-target-to-239

Baird analyst Eric Coldwell maintains Charles River (NYSE:CRL) with a Outperform and lowers the price target from $271 to $239.

 charles-river-and-aavantgarde-ink-cdmo-contract-to-produce-good-manufacturing-practice-plasmid-dna

Critical starting material manufacture for therapeutic targeting high unmet need ophthalmology indicationCharles River Laborato...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION